the world's headlines, one feed
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
We haven't written up this one. NPR has the full story — the link below goes straight to it.
→ One of the most influential pharma execs at Johnson & Johnson is retiring. Jennifer Taubert, the worldwide chair of Johnson & Johnson Innovative Medicine, will hand the reins to Tom ...
Bethany Worthey-Williams told Newsweek that her symptoms came out of nowhere, just days after giving birth to her second child.
[allAfrica] "Stay together."
Hong Kong is stepping up its efforts to invest in a cluster of biotech companies, positioning itself as a linchpin in Beijing’s push to reach new levels of innovation and challenge the United States…
The partnership will significantly strengthen Ireland's position within the European pharmaceutical research and innovation space. Read more: Rinn Pharma & Biopharma to join NordicPharmaTrain network